UK Life Sciences Company Directory

Bio-based compostable polymers and industrial materials development

Biome Bioplastics is a developer of renewable, biodegradable and compostable polymer materials for industrial applications. It formulates bio-based resins and tailored blends for films, coatings, injection moulding and other conventional plastics processing methods. Its research combines polymer chemistry, materials…

Stem cell-derived exosome platform for targeted drug delivery

ReNeuron is a biotechnology company developing a stem cell-derived exosome platform for targeted therapeutic delivery. Founded on over two decades of stem cell science, including the world's first clinical trial of conditionally immortalised neural stem cell therapy for stroke disability, the company has pivoted to…

Bispecific antibody-drug conjugates for cancer-selective precision therapy

BiVictriX Therapeutics is a biopharmaceutical company developing bispecific antibody-drug conjugates for targeted cancer treatment. Its Bi-Cygni platform recognises combinations of two tumour-associated antigens to improve cancer-cell selectivity and limit effects on healthy tissues. Its lead solid-tumour candidate,…

Automated bioreactor system for microbial culturing and measurement

ogibiotec is a life science instrumentation company developing automated, modular bioreactor systems for microbial culturing. Its platform replicates manual flask-culturing workflows for bacteria, yeast, algae, and bacteriophage, integrating retrofittable modules for optical density, pH, dissolved oxygen, and…

In vitro skin penetration and dermal absorption contract research

An-eX Analytical Services is an independent contract research organisation specialising in in vitro dermal absorption and skin penetration science. The company provides human skin penetration and permeation studies conducted to OECD 428 and related guidelines, alongside in vitro release testing, analytical method…

Preclinical neuroscience CRO for translational drug development research

Transpharmation is a preclinical neuroscience contract research organisation providing translational pharmacology services to pharmaceutical and biotechnology companies. The company's therapeutic expertise spans EEG, cognition, epilepsy, pain, neurodegeneration and mood disorders including treatment-resistant…

Bispecific antibody platform for cancer immunotherapies

F-star Therapeutics is a clinical-stage biotechnology company developing tetravalent bispecific antibodies for cancer and other serious diseases. Its proprietary platform creates antibodies with four binding sites that simultaneously target two different antigens, enabling focused immune activation in the tumour…

Antibody therapy to deplete amyloid deposits in ATTR cardiomyopathy

Immutrin is a biotechnology company developing an engineered antibody therapeutic designed to actively remove amyloid deposits from tissues in patients with amyloidosis. Its lead asset targets ATTR cardiomyopathy, a progressive and often fatal cardiac disease caused by transthyretin amyloid accumulation, for which no…

In vitro immunology CRO for pre-clinical drug development

Immundnz is a contract research organisation specialising in in vitro immunology services for pharmaceutical and biotechnology clients. The company designs and applies customised and standard immunological assays to assess immune safety, efficacy, and response to candidate therapeutics during pre-clinical development.…

Microbial conversion of biosolids into organic acids and nutrients

reNEW Technologies develops biological processes for recovering useful chemicals and nutrients from organic waste and sewage sludge. Its patented two-stage treatment combines fermentation and separation to produce volatile fatty acids and nutrient-rich fractions, which can be used in cleaning products, fertilisers and…

Serviced biotechnology laboratories and startup incubator

OpenCell is a London life sciences incubator and laboratory operator providing modular, serviced laboratory space for biotechnology startups. Its BioHotel facilities offer configurable BSL2+ laboratory units alongside shared scientific infrastructure, equipment access, storage, consumables management and operational…

Stem-cell disease models and multi-omics toxicology platforms

Stemnovate is a Cambridge biotechnology company developing human stem-cell models and multi-omics platforms for drug discovery and toxicology. Its induced pluripotent stem cell biobank supports reprogramming, differentiation and the development of disease-relevant cellular models. Genomic, transcriptomic, proteomic…

Rapid light-based point-of-care diagnostics for infections and pathogens

ExGen Dx, previously Linear Diagnostics, is a University of Birmingham spin-out developing a portable, light-based diagnostic platform that detects multiple infections from a single sample without laboratory equipment. The technology combines a patented optical detection method with a room-temperature amplification…

Engineered probiotic bacteria producing peptide therapeutics inside the body

Hijack Bio develops engineered probiotic bacteria designed to produce and release peptide therapeutics inside the body. The synthetic biology approach aims to reduce reliance on conventional external manufacturing and cold-chain distribution while enabling oral delivery of peptide drugs. Potential applications include…

Microplate consumables and instruments for life science laboratories

Porvair Sciences is a manufacturer of microplates, sample preparation consumables, and laboratory instruments for the life science and biotechnology industries. The company produces microplates across multiple formats and materials for applications spanning sample storage, solid phase extraction, cell culture, and…

Individualised neoantigen-based cell therapies for ovarian and solid cancers

Singula Bio is a seed-stage biotechnology company developing individualised, neoantigen-based cell therapies for patients with solid tumours, with an initial focus on ovarian cancer and other difficult-to-treat malignancies. The company's approach harnesses a patient's own immune system to target mutations that appear…

Biosurfactant manufacturer using yeast fermentation

Holiferm is a Manchester-based industrial biotech manufacturing biosurfactants from renewable feedstocks using a patented yeast fermentation process. The company produces sophorolipids for use in personal care, home care, and industrial cleaning applications as biodegradable, non-toxic alternatives to petrochemical…

The UK's largest single-ownership science and technology park near Oxford

Milton Park is the UK's largest single-ownership science, business and technology park, located in South Oxfordshire between Abingdon and Didcot. Spanning 300 acres with nearly three million square feet of floor space, it hosts over 270 organisations across life sciences, energy, space and supporting technologies, and…

Point-of-care pharmacogenetic testing platform for emergency healthcare

Genedrive is a molecular diagnostics company developing point-of-need pharmacogenetic tests that identify genetic variants to guide safer, more personalised medicine decisions in time-critical emergency care. Its flagship products, developed and validated with NHS partners, include a neonatal test preventing…

Plant protein materials replacing plastics and microplastics

Xampla is a Cambridge-based materials innovation company developing plant protein-based alternatives to single-use plastics and synthetic microplastics. Its range of products includes biodegradable coatings, soluble films, edible films, and microcapsules derived from sustainable vegetable proteins such as pea,…